| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-06 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-05 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.13 | 8e-05 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0007 |